Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain MetastasesCLINICAL CANCER RESEARCHIF10.22023-02-1615OA
Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade AstrocytomasCLINICAL CANCER RESEARCHIF10.22021-03-3022OA
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)QUALITY OF LIFE RESEARCHIF2.72013-07-20115OA